Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deuruxolitinib in Severe Alopecia Areata
NCT07617597Phase 3Recruiting
- Sponsor
- Sun Pharma
- Start
- Jun 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
A Phase 3 trial of deuruxolitinib in alopecia areata, sponsored by Sun Pharma. Started Jun 2026; status: recruiting.
02
Drugs
deuruxolitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT07617597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07617597.